相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Developing a Clinical Decision Model: MR Spectroscopy to Differentiate Between Recurrent Tumor and Radiation Change in Patients with New Contrast-Enhancing Lesions
Ethan A. Smith et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2009)
A Vascular Normalization Index as Potential Mechanistic Biomarker to Predict Survival after a Single Dose of Cediranib in Recurrent Glioblastoma Patients
A. Gregory Sorensen et al.
CANCER RESEARCH (2009)
Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy
Suja Saraswathy et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Detecting an Overall Survival Benefit that Is Derived From Progression-Free Survival
Kristine R. Broglio et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide
Walter Taal et al.
CANCER (2008)
Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: Pitfalls in neurooncology
Alba A. Brandes et al.
NEURO-ONCOLOGY (2008)
Comparison of Dynamic Susceptibility-weighted Contrast-enhanced MR Methods: Recommendations for Measuring Relative Cerebral Blood Volume in Brain Tumors
Eric S. Paulson et al.
RADIOLOGY (2008)
Low-grade gliomas:: Do changes in rCBV measurements at longitudinal perfusion-weighted MR imaging predict malignant transformation?
Nasuda Danchaivijitr et al.
RADIOLOGY (2008)
Gliomas: Predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging
Meng Law et al.
RADIOLOGY (2008)
Diffusion magnetic resonance imaging: A biomarker for treatment response in oncology
Daniel A. Hamstra et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Differentiation of recurrent brain tumor versus radiation injury using diffusion tensor imaging in patients with new contrast-enhancing lesions
Pia C. Sundgren et al.
MAGNETIC RESONANCE IMAGING (2006)
Clinical investigation survival prediction in high-grade gliomas by MRI perfusion before and during early stage of RT
Y Cao et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Low-grade gliomas: Dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging - Prediction of patient clinical response
M Law et al.
RADIOLOGY (2006)
Comparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomas
GD Shah et al.
NEURO-ONCOLOGY (2006)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Survival analysis in patients with glioblastoma multiforme: Predictive value of choline-to-N-acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume
J Oh et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2004)
Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: Correlation with histopathology
S Cha et al.
MAGNETIC RESONANCE IN MEDICINE (2003)
Dynamic susceptibility contrast MRI of gliomas
HJ Aronen et al.
NEUROIMAGING CLINICS OF NORTH AMERICA (2002)